Aug 6, 2026 07:17AM
Aug 6, 2026 07:00AM
Jul 23, 2026 07:00AM
Jul 21, 2026 05:03AM
Jul 16, 2026 09:56AM
Jul 14, 2026 09:00AM
Jul 14, 2026 09:00AM Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
Jul 9, 2026 05:13AM
May 12, 2026 04:18PM
May 7, 2026 07:42AM
May 7, 2026 07:00AM
Apr 27, 2026 02:55PM
Apr 27, 2026 07:01AM
Apr 27, 2026 07:00AM Ligand to acquire XOMA Royalty for $739 million in cash deal
Apr 27, 2026 07:00AM
Apr 27, 2026 07:00AM
Apr 22, 2026 07:00AM
Feb 26, 2026 07:11AM
Feb 26, 2026 07:00AM
Feb 12, 2026 07:00AM
Dec 10, 2025 08:46AM Benchmark Reiterates Buy Rating on Ligand Pharma (LGND) Following Strong Forecasts for 2025/26
Dec 9, 2025 07:00AM
Nov 10, 2025 04:10PM
Nov 6, 2025 07:21AM
Nov 6, 2025 07:00AM
Oct 23, 2025 07:00AM
Sep 2, 2025 07:37AM
Aug 7, 2025 07:12AM Ligand Pharma (LGND) Tops Q2 EPS by 17c ; Offers Guidance
Aug 7, 2025 07:00AM
Jul 24, 2025 07:00AM
Jul 2, 2025 07:01AM
Jul 2, 2025 07:00AM
Jul 2, 2025 07:00AM
May 8, 2025 07:14AM
May 8, 2025 07:00AM Ligand Reports First Quarter 2025 Financial Results
Apr 24, 2025 07:00AM
Apr 17, 2025 06:00AM
Feb 27, 2025 07:12AM
Feb 27, 2025 07:00AM
Feb 13, 2025 07:00AM
Dec 23, 2024 10:18AM
Dec 10, 2024 09:15AM Ligand Pharma (LGND) Introduces 2025 Guidance
Dec 10, 2024 09:00AM
Nov 7, 2024 07:17AM
Nov 7, 2024 07:00AM
Oct 23, 2024 04:01PM
Aug 6, 2024 04:01PM
Jul 23, 2024 04:01PM
Jul 9, 2024 08:50AM Ligand Pharma (LGND) PT Raised to $140 at Craig-Hallum
Jul 8, 2024 07:03AM

1,219,404 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All